Patient’s Own Infection-fighting T Cells Put Late-stage Melanoma Into Long-term Remission

Researchers describe the first successful use of a human patient’s cloned infection-fighting T cells as the sole therapy to put an advanced solid-tumor cancer into long-term remission.